Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BAYN.SW
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.86 1.31 1.27
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -42.47 9.55 16.59
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 8.13 36.24 33.52
Cash -15.73 9.08 10.78
Capex 55.22 -0.45 -1.01
Free Cash Flow -43.70 -2.64 4.69
Revenue 16.04 14.01 12.07
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.01 0.60 0.62
Operating Margin 50.45 0.22 0.15
ROA 45.07 0.02 0.01
ROE 38.34 0.06 0.04
ROIC 53.00 0.03 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BAYN.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BAYN.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BAYN.SW is permitted for members.